(BUD) Anheuser Busch Inbev - Overview
Exchange: NYSE •
Country: Belgium •
Currency: USD •
Type: Common Stock •
ISIN: US03524A1088
Stock: Beer, Malt Beverages, Soft Drinks, Spirits
Total Rating 47
Risk 68
Buy Signal -0.82
| Risk 5d forecast | |
|---|---|
| Volatility | 21.9% |
| Relative Tail Risk | -6.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | 7.70 |
| Character TTM | |
|---|---|
| Beta | -0.044 |
| Beta Downside | -0.259 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.55% |
| CAGR/Max DD | 0.18 |
EPS (Earnings per Share)
Revenue
Description: BUD Anheuser Busch Inbev March 04, 2026
Anheuser-Busch InBev SA/NV (BUD) is a global beverage company. It produces and sells beer, flavored malt beverages, soft drinks, spirit-based cocktails, and energy drinks across multiple continents.
The company operates through six geographic segments, demonstrating a diversified market presence. Its product portfolio includes approximately 500 beer brands, such as Budweiser and Corona Extra, alongside non-beer brands. The global beer market is characterized by consolidation and a focus on premiumization.
BUD also utilizes digital platforms like BEES for business-to-business commerce and Zé Delivery for on-demand delivery, indicating an investment in direct-to-consumer strategies. The beverage industry increasingly leverages e-commerce for distribution.
For more detailed financial analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Global beer consumption trends impact revenue
- Raw material costs influence profit margins
- Regulatory changes in alcohol sales affect operations
- Currency fluctuations impact international earnings
- Competition from craft breweries erodes market share
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 9.56b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.29 > 1.0 |
| NWC/Revenue: -10.86% < 20% (prev -13.46%; Δ 2.60% < -1%) |
| CFO/TA 0.07 > 3% & CFO 14.84b > Net Income 9.56b |
| Net Debt (61.39b) to EBITDA (27.47b): 2.23 < 3 |
| Current Ratio: 0.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.98b) vs 12m ago -1.26% < -2% |
| Gross Margin: 56.07% > 18% (prev 0.46%; Δ 5.56k% > 0.5%) |
| Asset Turnover: 42.02% > 50% (prev 36.21%; Δ 5.81% > 0%) |
| Interest Coverage Ratio: 2.47 > 6 (EBITDA TTM 27.47b / Interest Expense TTM 7.81b) |
Altman Z'' 1.52
| A: -0.04 (Total Current Assets 24.77b - Total Current Liabilities 34.48b) / Total Assets 218.81b |
| B: 0.23 (Retained Earnings 50.13b / Total Assets 218.81b) |
| C: 0.09 (EBIT TTM 19.33b / Avg Total Assets 212.72b) |
| D: 0.43 (Book Value of Equity 51.86b / Total Liabilities 121.07b) |
| Altman-Z'' Score: 1.52 = BB |
Beneish M -3.02
| DSRI: 1.06 (Receivables 6.95b/5.50b, Revenue 89.38b/74.81b) |
| GMI: 0.83 (GM 56.07% / 46.43%) |
| AQI: 1.00 (AQ_t 0.78 / AQ_t-1 0.77) |
| SGI: 1.19 (Revenue 89.38b / 74.81b) |
| TATA: -0.02 (NI 9.56b - CFO 14.84b) / TA 218.81b) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
What is the price of BUD shares?
As of March 20, 2026, the stock is trading at USD 69.27 with a total of 3,758,806 shares traded.
Over the past week, the price has changed by -3.71%, over one month by -12.06%, over three months by +7.41% and over the past year by +11.94%.
Over the past week, the price has changed by -3.71%, over one month by -12.06%, over three months by +7.41% and over the past year by +11.94%.
Is BUD a buy, sell or hold?
Anheuser Busch Inbev has received a consensus analysts rating of 4.15.
Therefore, it is recommended to buy BUD.
- StrongBuy: 5
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BUD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 89.9 | 29.8% |
| Analysts Target Price | 89.9 | 29.8% |
BUD Fundamental Data Overview March 17, 2026
P/E Trailing = 21.354
P/E Forward = 16.9205
P/S = 2.3834
P/B = 1.614
P/EG = 1.7156
Revenue TTM = 89.38b USD
EBIT TTM = 19.33b USD
EBITDA TTM = 27.47b USD
Long Term Debt = 70.35b USD (from longTermDebt, last quarter)
Short Term Debt = 899.0m USD (from shortTermDebt, last quarter)
Debt = 73.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.39b USD (from netDebt column, last quarter)
Enterprise Value = 202.46b USD (141.38b + Debt 73.03b - CCE 11.94b)
Interest Coverage Ratio = 2.47 (Ebit TTM 19.33b / Interest Expense TTM 7.81b)
EV/FCF = 18.08x (Enterprise Value 202.46b / FCF TTM 11.20b)
FCF Yield = 5.53% (FCF TTM 11.20b / Enterprise Value 202.46b)
FCF Margin = 12.53% (FCF TTM 11.20b / Revenue TTM 89.38b)
Net Margin = 10.70% (Net Income TTM 9.56b / Revenue TTM 89.38b)
Gross Margin = 56.07% ((Revenue TTM 89.38b - Cost of Revenue TTM 39.26b) / Revenue TTM)
Gross Margin QoQ = 55.88% (prev 56.41%)
Tobins Q-Ratio = 0.93 (Enterprise Value 202.46b / Total Assets 218.81b)
Interest Expense / Debt = 3.09% (Interest Expense 2.25b / Debt 73.03b)
Taxrate = 23.63% (1.38b / 5.83b)
NOPAT = 14.76b (EBIT 19.33b * (1 - 23.63%))
Current Ratio = 0.72 (Total Current Assets 24.77b / Total Current Liabilities 34.48b)
Debt / Equity = 0.84 (Debt 73.03b / totalStockholderEquity, last quarter 87.29b)
Debt / EBITDA = 2.23 (Net Debt 61.39b / EBITDA 27.47b)
Debt / FCF = 5.48 (Net Debt 61.39b / FCF TTM 11.20b)
Total Stockholder Equity = 87.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.49% (Net Income 9.56b / Total Assets 218.81b)
RoE = 10.99% (Net Income TTM 9.56b / Total Stockholder Equity 87.02b)
RoCE = 12.28% (EBIT 19.33b / Capital Employed (Equity 87.02b + L.T.Debt 70.35b))
RoIC = 9.40% (NOPAT 14.76b / Invested Capital 157.12b)
WACC = 4.59% (E(141.38b)/V(214.41b) * Re(5.75%) + D(73.03b)/V(214.41b) * Rd(3.09%) * (1-Tc(0.24)))
Discount Rate = 5.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF] Terminal Value 86.31% ; FCFF base≈11.19b ; Y1≈11.16b ; Y5≈11.75b
[DCF] Fair Price = 167.8 (EV 350.67b - Net Debt 61.39b = Equity 289.28b / Shares 1.72b; r=5.90% [WACC]; 5y FCF grow -0.88% → 2.90% )
EPS Correlation: 66.05 | EPS CAGR: 13.04% | SUE: 0.85 | # QB: 1
Revenue Correlation: 11.87 | Revenue CAGR: 25.05% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.12 | Chg7d=+1.120 | Chg30d=+1.120 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=4.37 | Chg7d=+0.000 | Chg30d=+0.192 | Revisions Net=+6 | Growth EPS=+17.0% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=4.93 | Chg7d=+0.000 | Chg30d=+0.173 | Revisions Net=+5 | Growth EPS=+12.9% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 7.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = +5.4% (Analyst 8.7% - Implied 3.3%)
P/E Forward = 16.9205
P/S = 2.3834
P/B = 1.614
P/EG = 1.7156
Revenue TTM = 89.38b USD
EBIT TTM = 19.33b USD
EBITDA TTM = 27.47b USD
Long Term Debt = 70.35b USD (from longTermDebt, last quarter)
Short Term Debt = 899.0m USD (from shortTermDebt, last quarter)
Debt = 73.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 61.39b USD (from netDebt column, last quarter)
Enterprise Value = 202.46b USD (141.38b + Debt 73.03b - CCE 11.94b)
Interest Coverage Ratio = 2.47 (Ebit TTM 19.33b / Interest Expense TTM 7.81b)
EV/FCF = 18.08x (Enterprise Value 202.46b / FCF TTM 11.20b)
FCF Yield = 5.53% (FCF TTM 11.20b / Enterprise Value 202.46b)
FCF Margin = 12.53% (FCF TTM 11.20b / Revenue TTM 89.38b)
Net Margin = 10.70% (Net Income TTM 9.56b / Revenue TTM 89.38b)
Gross Margin = 56.07% ((Revenue TTM 89.38b - Cost of Revenue TTM 39.26b) / Revenue TTM)
Gross Margin QoQ = 55.88% (prev 56.41%)
Tobins Q-Ratio = 0.93 (Enterprise Value 202.46b / Total Assets 218.81b)
Interest Expense / Debt = 3.09% (Interest Expense 2.25b / Debt 73.03b)
Taxrate = 23.63% (1.38b / 5.83b)
NOPAT = 14.76b (EBIT 19.33b * (1 - 23.63%))
Current Ratio = 0.72 (Total Current Assets 24.77b / Total Current Liabilities 34.48b)
Debt / Equity = 0.84 (Debt 73.03b / totalStockholderEquity, last quarter 87.29b)
Debt / EBITDA = 2.23 (Net Debt 61.39b / EBITDA 27.47b)
Debt / FCF = 5.48 (Net Debt 61.39b / FCF TTM 11.20b)
Total Stockholder Equity = 87.02b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.49% (Net Income 9.56b / Total Assets 218.81b)
RoE = 10.99% (Net Income TTM 9.56b / Total Stockholder Equity 87.02b)
RoCE = 12.28% (EBIT 19.33b / Capital Employed (Equity 87.02b + L.T.Debt 70.35b))
RoIC = 9.40% (NOPAT 14.76b / Invested Capital 157.12b)
WACC = 4.59% (E(141.38b)/V(214.41b) * Re(5.75%) + D(73.03b)/V(214.41b) * Rd(3.09%) * (1-Tc(0.24)))
Discount Rate = 5.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF] Terminal Value 86.31% ; FCFF base≈11.19b ; Y1≈11.16b ; Y5≈11.75b
[DCF] Fair Price = 167.8 (EV 350.67b - Net Debt 61.39b = Equity 289.28b / Shares 1.72b; r=5.90% [WACC]; 5y FCF grow -0.88% → 2.90% )
EPS Correlation: 66.05 | EPS CAGR: 13.04% | SUE: 0.85 | # QB: 1
Revenue Correlation: 11.87 | Revenue CAGR: 25.05% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.12 | Chg7d=+1.120 | Chg30d=+1.120 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=4.37 | Chg7d=+0.000 | Chg30d=+0.192 | Revisions Net=+6 | Growth EPS=+17.0% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=4.93 | Chg7d=+0.000 | Chg30d=+0.173 | Revisions Net=+5 | Growth EPS=+12.9% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: +0.75 (7 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.3% (Discount Rate 7.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = +5.4% (Analyst 8.7% - Implied 3.3%)